SG

Shashi Gautam

Director DIN 00529930
DIN 00529930 First appointment Dec 2000
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2000
Shareholding value β€’β€’β€’β€’ Premium profile

About Shashi Gautam

Data last updated:

Shashi Gautam was a Director at Vikas Pharma India Private Limited (from 2000) and Director at Solumax Lifesciences Private Limited (from 2012).

DIN 00529930
First Appointment 22 Dec 2000
Oldest Company Age 33 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vikas Pharma India Private Limited U74899DL1993PTC055479
Director22 Dec 20001993Strike Off
Solumax Lifesciences Private Limited U24232DL2012PTC231677
Director17 Feb 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vikas Pharma India Private Limited
Solumax Lifesciences Private Limited
Premium access

Shareholding and investment profile for Shashi Gautam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi Gautam

Shashi Gautam was first appointed on 22 Dec 2000 as Director at Vikas Pharma India Private Limited. The most recent appointment on record is 17 Feb 2012 at Solumax Lifesciences Private Limited.

Shashi Gautam held 2 earlier board appointments: Vikas Pharma India Private Limited (Director, from 22 Dec 2000); Solumax Lifesciences Private Limited (Director, from 17 Feb 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available